| rs712829 |
chr7 |
55086755 |
1 |
G |
T |
Drug response to Gefitinib |
EGFR |
UTR-5 |
17375033
|
| rs712829 |
chr7 |
55086755 |
1 |
G |
T |
Drug response to Erlotinib |
EGFR |
UTR-5 |
18006781
|
| rs712829 |
chr7 |
55086755 |
1 |
G |
T |
Drug response to Erlotinib |
EGFR |
UTR-5 |
18652519
|
| rs712829 |
chr7 |
55086755 |
1 |
G |
T |
Drug response to Geldanamycin |
EGFR |
UTR-5 |
18652519
|
| rs12538489 |
chr7 |
55099836 |
0.00046 |
C |
T |
Smoking initiation |
EGFR |
intron |
24665060
|
| rs6956366 |
chr7 |
55101501 |
0.00028 |
G |
C,T |
HDL particle features |
EGFR |
intron |
21283740
|
| rs1015793 |
chr7 |
55114316 |
0.000224 |
A |
G |
Smoking initiation |
EGFR |
intron |
24665060
|
| rs17172430 |
chr7 |
55122650 |
0.000366 |
G |
A |
Alzheimer's disease (late onset) |
EGFR |
intron |
21379329
|
| rs17172430 |
chr7 |
55122650 |
0.000194 |
G |
A |
Smoking initiation |
EGFR |
intron |
24665060
|
| rs729969 |
chr7 |
55128207 |
0.0000000836 |
A |
G |
Bipolar disorder |
EGFR |
intron |
18317468
|
| rs1344307 |
chr7 |
55137888 |
0.00003 |
G |
A |
Lung function (forced expiratory flow between 25% and 75% of forced vital capacity) |
EGFR |
intron |
24023788
|
| rs10488140 |
chr7 |
55138388 |
0.000000102 |
C |
T |
Bipolar disorder |
EGFR |
intron |
18317468
|
| rs17586365 |
chr7 |
55140786 |
0.000325 |
G |
A |
Smoking initiation |
EGFR |
intron |
24665060
|
| rs17172438 |
chr7 |
55151537 |
0.000000928 |
T |
C |
Bipolar disorder |
EGFR |
intron |
18317468
|
| rs17172438 |
chr7 |
55151537 |
0.000735 |
T |
C |
Smoking initiation |
EGFR |
intron |
24665060
|
| rs7785013 |
chr7 |
55152667 |
0.000408 |
G |
A |
Smoking initiation |
EGFR |
intron |
24665060
|
| rs11979158 |
chr7 |
55159349 |
0.00000007 |
A |
G |
Glioma |
EGFR |
intron |
21531791
|
| rs4947491 |
chr7 |
55169291 |
0.0000976 |
A |
G |
Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin) |
EGFR |
intron |
23648065
|
| rs2877260 |
chr7 |
55171629 |
0.000047 |
A |
G |
Alcoholism (heaviness of drinking) |
EGFR |
intron |
21529783
|
| rs7803660 |
chr7 |
55174071 |
0.00000197 |
C |
G |
Triglycerides |
EGFR |
intron |
23063622
|
| rs980653 |
chr7 |
55185890 |
0.000886 |
C |
T |
Multiple complex diseases |
EGFR |
intron |
17554300
|
| rs9649847 |
chr7 |
55187138 |
0.0000983 |
G |
A |
HDL cholesterol |
EGFR |
intron |
pha003074
|
| rs2072454 |
chr7 |
55214348 |
0.000088 |
C |
T |
Diabetic retinopathy |
EGFR |
cds-synon |
21441570
|
| rs2072454 |
chr7 |
55214348 |
0.00002 |
C |
T |
Prostate cancer |
EGFR |
cds-synon |
21743057
|
| rs2270247 |
chr7 |
55214647 |
0.000098 |
G |
T |
Diabetic retinopathy |
EGFR |
intron |
21441570
|
| rs2270247 |
chr7 |
55214647 |
0.00002 |
G |
T |
Prostate cancer |
EGFR |
intron |
21743057
|
| rs730437 |
chr7 |
55215018 |
0.000066 |
A |
C |
Diabetic retinopathy |
EGFR |
intron |
21441570
|
| rs730437 |
chr7 |
55215018 |
0.00002 |
A |
C |
Prostate cancer |
EGFR |
intron |
21743057
|
| rs2075109 |
chr7 |
55218903 |
0.0000988 |
T |
C |
Serum metabolites |
EGFR |
intron |
19043545
|
| rs2075110 |
chr7 |
55219159 |
0.0000998 |
C |
T |
Serum metabolites |
EGFR |
intron |
19043545
|
| rs138847501 |
chr7 |
55221725 |
0.00023 |
G |
A |
Breast cancer |
EGFR |
missense |
23555315
|
| rs1558544 |
chr7 |
55228053 |
0.000411 |
A |
T |
Alzheimer's disease |
EGFR |
intron |
22005930
|
| rs2227983 |
chr7 |
55229255 |
1 |
G |
A,C,T |
Drug response to Erlotinib |
EGFR |
missense |
18006781
|
| rs7781264 |
chr7 |
55230840 |
0.000473 |
A |
G |
Alzheimer's disease |
EGFR |
intron |
22005930
|
| rs10081281 |
chr7 |
55236796 |
0.000712 |
C |
T |
Telomere length |
EGFR |
intron |
23900074
|
| rs845559 |
chr7 |
55247960 |
0.000676 |
C |
T |
Cervical cancer |
EGFR |
intron |
21716314
|
| rs6593210 |
chr7 |
55254186 |
0.0000206 |
G |
A |
Height |
EGFR |
intron |
pha003011
|
| rs6970262 |
chr7 |
55259763 |
0.0000947 |
A |
G |
Non-alcoholic fatty liver disease histology (other) |
EGFR |
intron |
20708005
|